Genz-644282

· Genzyme (a Sanofi company)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Genz-644282, covering 2014-03-19 to 2014-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors [Phase 1]

See pricing